News Menu

Lucas Cheadle named a 2022 NIH Director鈥檚 New Innovator

photo of Lucas Cheadle
黑料吃瓜资源 Assistant Professor Lucas Cheadle

黑料吃瓜资源 (CSHL) Assistant Professor Lucas Cheadle has been named CSHL鈥檚 first recipient of the . He will use the $1.5 million grant to investigate the links between inflammation and autism spectrum disorders.

鈥淚 am extremely pleased to receive this award,鈥 Cheadle says. 鈥淭his is a unique opportunity. If we can establish a better understanding of how inflammation impacts brain development, we can build therapies to ameliorate the symptoms and improve the lives of individuals with autism and other neurodevelopmental disorders.鈥

Established in 2007, the NIH Director鈥檚 New Innovator Award supports early career researchers working on innovative, high-impact projects in the biomedical, behavioral, or social sciences. It is part of the NIH鈥檚 . 鈥淭his unique cohort of scientists will transform what is known in the biological and behavioral world,鈥 Lawrence A. Tabak, D.D.S., Ph.D., who is performing the duties of the director of NIH, says.

鈥淚 congratulate Lucas Cheadle for his recognition by the National Institutes of Health as CSHL鈥檚 first recipient of the NIH Director鈥檚 New Innovator Award,鈥 CSHL President and CEO Bruce Stillman says. 鈥淭his award underscores Lucas鈥 exceptional ingenuity and will support his lab鈥檚 pioneering research into the links between inflammation and autism spectrum disorders.鈥

Written by: Nick Wurm, Communications Specialist | [email protected] | 516-367-5940

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup